These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38947813)

  • 41. In vitro antiviral activity of piperidine alkaloids from Senna spectabilis flowers on Chikungunya virus infection.
    Freitas TR; Novais RM; Santos IA; Martins DOS; Danuello A; da Silva Bolzani V; Jardim ACG; Pivatto M
    Pharmacol Rep; 2022 Aug; 74(4):752-758. PubMed ID: 35882766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro.
    Troost B; Mulder LM; Diosa-Toro M; van de Pol D; Rodenhuis-Zybert IA; Smit JM
    Sci Rep; 2020 Apr; 10(1):6364. PubMed ID: 32286447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease.
    Singh H; Mudgal R; Narwal M; Kaur R; Singh VA; Malik A; Chaudhary M; Tomar S
    Biochimie; 2018 Jun; 149():51-61. PubMed ID: 29635044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro.
    Ayusso GM; da Silva Sanches PR; Carvalho T; Santos IA; Martins DOS; Lima MLD; da Conceição PJP; Bittar C; Merits A; Cilli EM; Jardim ACG; Rahal P; Calmon MF
    Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.
    Langsjoen RM; Haller SL; Roy CJ; Vinet-Oliphant H; Bergren NA; Erasmus JH; Livengood JA; Powell TD; Weaver SC; Rossi SL
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
    Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate.
    Freire MCLC; Basso LGM; Mendes LFS; Mesquita NCMR; Mottin M; Fernandes RS; Policastro LR; Godoy AS; Santos IA; Ruiz UEA; Caruso IP; Sousa BKP; Jardim ACG; Almeida FCL; Gil LHVG; Andrade CH; Oliva G
    Sci Rep; 2022 Jun; 12(1):10601. PubMed ID: 35732685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors.
    Kumar P; Kumar D; Giri R
    Pathogens; 2019 Aug; 8(3):. PubMed ID: 31443266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro Studies on The Inhibition of Replication of Zika and Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus cervicornis.
    Cirne-Santos CC; de Souza Barros C; de Oliveira MC; Rabelo VW; Azevedo RC; Teixeira VL; Ferreira DF; de Palmer Paixão ICN
    Sci Rep; 2020 May; 10(1):8263. PubMed ID: 32427940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries.
    Khongwichit S; Chansaenroj J; Chirathaworn C; Poovorawan Y
    J Biomed Sci; 2021 Dec; 28(1):84. PubMed ID: 34857000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
    Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN
    Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus.
    Santos IA; Shimizu JF; de Oliveira DM; Martins DOS; Cardoso-Sousa L; Cintra ACO; Aquino VH; Sampaio SV; Nicolau-Junior N; Sabino-Silva R; Merits A; Harris M; Jardim ACG
    Sci Rep; 2021 Apr; 11(1):8717. PubMed ID: 33888774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A combination of doxycycline and ribavirin alleviated chikungunya infection.
    Rothan HA; Bahrani H; Mohamed Z; Teoh TC; Shankar EM; Rahman NA; Yusof R
    PLoS One; 2015; 10(5):e0126360. PubMed ID: 25970853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Memantine hydrochloride: a drug to be repurposed against Chikungunya virus?
    Pereira AKDS; Santos IA; da Silva WW; Nogueira FAR; Bergamini FRG; Jardim ACG; Corbi PP
    Pharmacol Rep; 2021 Jun; 73(3):954-961. PubMed ID: 33523405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity
    De S; Ghosh S; Keshry SS; Mahish C; Mohapatra C; Guru A; Mamidi P; Datey A; Pani SS; Vasudevan D; Beuria TK; Chattopadhyay S; Subudhi BB; Chattopadhyay S
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0046322. PubMed ID: 35766508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches?
    Shimizu JF; Martins DOS; McPhillie MJ; Roberts GC; Zothner C; Merits A; Harris M; Jardim ACG
    Acta Trop; 2020 Jul; 207():105490. PubMed ID: 32333884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection.
    Tran QTN; Lee RCH; Liu HJ; Ran D; Low VZL; To DQ; Chu JJH; Chai CLL
    Eur J Med Chem; 2022 Feb; 230():114110. PubMed ID: 35085859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Dimeric Peptide (KKYRYHLKPF)
    Ayusso GM; Lima MLD; da Silva Sanches PR; Santos IA; Martins DOS; da Conceição PJP; Carvalho T; da Costa VG; Bittar C; Merits A; Santos-Filho NA; Cilli EM; Jardim ACG; de Freitas Calmon M; Rahal P
    Viruses; 2023 May; 15(5):. PubMed ID: 37243254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.